Program
Global Cardio-Oncology Summit 2018
For your convenience, you may also print this program.
Thursday, September 27, 2018
7:00 a.m. – 7:00 p.m.
| Time | Topic | Location / Speaker |
|---|---|---|
| 7:00 - 8:00 | Breakfast (provided) & Registration | |
| 8:00 - 8:15 | GCOS 2018 Welcome & Introduction | Co-Chairs: Dr. Michael Fradley & Dr. Roohi Ismail-Khan |
Chairs: Dr. Jean-Bernard Durand & Dr. Zaza Iakobishvili |
||
| 8:15 - 8:45 | Plenary Lecture: Cardio-Oncology Historical Perspective: Past, Present, Future | Dr. Susan Dent Professor of Medicine, Associate Director of Breast Cancer Research and Co-Director of Cardio-Oncology, Duke University, Durham, NC, USA; Founder & Past-President, Canadian Cardiac Oncology Network |
| 8:45 - 9:15 | Patient Perspective | Ms. Abby Jones & Ms. Nancy Smith |
| 9:15 - 9:30 | Discussion | |
| 9:30 - 9:50 | Break with Snacks | |
Chairs: Dr. Javier Pinilla-Ibarz & Dr. John Groarke |
||
| 9:50 - 10:10 | Modern Treatments for Breast Cancer: From Anthracyclines to CD4/6 Inhibitors | Dr. Roohi Ismail Khan Co-Director, Cardio-Oncology Program, Associate Member, Department of Breast Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA |
| 10:10 - 10:30 | Cardiovascular Safety of Proteasome Inhibitors and Immunomodulatory Drugs for the Treatment of Multiple Myeloma | Dr. Sagar Lonial Professor and Chair, Department of Hematology and Medical Oncology, Chief Medical Officer, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA |
| 10:30 - 10:50 | Cardiotoxicities of Tyrosine Kinase Inhibitors to Treat CML and CLL: Heart Attacks, Strokes and Atrial Fibrillation Oh My! | Dr. Michael Mauro Leader, Myeloproliferative Neoplasms Program, Leukemia Service, Professor of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA |
| 10:50 - 11:00 | Case Presentations: Challenges in the diagnosis and management of treatment-emergent cardiotoxicity | Dr. Isaac Rhea & Dr. Li Ling Tan |
| 11:00 - 11:20 | Panel Discussion and Questions | |
Chairs: Dr. Javid Moslehi & Dr. Susannah Stanway |
||
| 11:20 - 12:00 | The Role of Social Media in Promoting the Field of Cardio-Oncology with Tweeting Workshop and Audience Participation | Dr. Naveen Pemmaraju Associate Professor, Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA |
| 12:00 - 12:15 | Questions | |
| 12:15 - 1:30 | Lunch (provided) | |
Chairs: Dr. Gregory Armstrong & Dr. Sebastian Szmit |
||
| 1:30 - 1:50 | Unique Cardiovascular Issues Facing Paediatric Cancer Survivors | Dr. Paul Nathan Director, Aftercare Program and Staff Oncologist, Hospital for Sick Children; Professor of Pediatrics and Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada |
| 1:50 - 2:10 | Cardiovascular Considerations in the Geriatric Patient with Cancer | Dr. Martine Extermann Professor of Oncology and Medicine, University of South Florida; Program Leader, Senior Adult Oncology Program, Moffitt Cancer Center and Research Institute, Tampa, FL, USA |
| 2:10 - 2:30 | Minimizing Cardiovascular Complications in Patients with High Cancer Risk Genetic Syndromes (BRCA, Li Fraumeni Syndrome) | Dr. Kathryn Ruddy Consultant, Associate Professor of Oncology, Director of Cancer Survivorship, Department of Oncology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA |
| 2:30 - 2:40 | Case Presentations: Can Risk Factor Modification Impact the Development of Cardiotoxicity? | Dr. Merna Armanious & Dr. Sara Dost |
| 2:40 - 3:00 | Panel Discussion | |
| 3:00 - 3:30 | Break with Snacks | |
Moderator: Dr. Margot Davis |
||
| 3:30 - 4:15 | Should Direct Oral Anticoagulants Be Utilized in Cancer Patients to Prevent Thrombosis? 10-minute presentations with 5 minutes of rebuttal; 15 minutes of questions | YES: Dr. Chiara Melloni Associate Professor of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA NO: Dr. Kristen Sanfilippo Assistant Professor, Department of Medicine, Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA |
Chair: Dr. Bonnie Ky Judges: Dr. Anne Blaes, Dr. Chau Dang & Dr. Carlo Tocchetti |
||
| 4:15 - 4:30 | Global Longitudinal Strain and Myocarditis with Immune Checkpoint Inhibitors 5 minute discussion | Dr. Magid Awadalla Cardiac Imaging Research Fellow, Massachusetts General Hospital, Harvard Medical School Boston, MA, USA |
| 4:30 - 4:45 | Prospective Study of Cardiac Events During Proteasome Therapy for Relapsed Multiple Myeloma 5 minute discussion | Dr. Cherie Dahm Internal Medicine Resident, Vanderbilt University Medical Center, Nashville, TN, USA |
| 4:45 - 5:00 | A Diagnostic Score of Cardiac Involvement in AL Amyloidosis 5 minute discussion | Dr. Martin Nicol Cardiology Resident, Lariboisiere Hospital, Paris Diderot Université Paris, France |
Introduction by Dr. Susan Dent |
||
| 5:00-5:30 | Dr. Daniela Cardinale Director, Cardio-Oncology Unit, European Institute of Oncology, Milan, Italy | |
| 5:30 - 7:00 | Poster Reception With Wine & Light Appetizers |
|
| 7:30 - 10:00 | GCOS 2018 Conference Dinner Tampa Club (separate registration required) |
|
Friday, September 28, 2018
7:30 a.m. – 5:00 p.m.
| Time | Topic | Location / Speaker |
|---|---|---|
| 7:30 - 8:00 | Breakfast (provided) | |
| 8:00 - 8:10 | Opening Remarks and Day 1 Overview | Co-Chairs: Dr. Michael Fradley & Dr. Roohi Ismail-Khan |
| 8:10 - 8:15 | Announcement of the Young Investigator Award Winner | Dr. Bonnie Ky |
Chairs: Dr. Alain Cohen-Solal & Dr. Christine Simmons |
||
| 8:15 - 9:00 | Reconciling Guidelines, Recommendations and Consensus Statements to Provide Optimal Cardio-Oncology Care | Dr. Saro Armenian Associate Professor, Department of Paediatrics and Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA, USA |
Chairs: Dr. Negar Mousavi & Dr. Kenneth Shain |
||
| 9:00 - 9:20 | Amyloidosis: Challenges in Diagnosis and Management | Dr. Ronald Witteles Co-Director, Stanford Amyloid Center, Director, Internal Medicine Residency Program, Associate Professor of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA |
| 9:20 - 9:40 | Cardiovascular Issues Due to Carcinoid and Other Neuroendocrine Tumors | Dr. Jonathan Strosberg Section Head, Neuroendocrine Division, Associate Professor, Moffitt Cancer Center and Research Institute, Tampa, FL, USA |
| 9:40 - 10:00 | Cardiac Tumors: Clinical and Imaging Evalution of Benign and Malignant Lesions | Dr. W. Gregory Hundley Program Director, Cardiovascular Imaging Training Program, Professor of Cardiology and Radiology, Wake Forest School of Medicine, Baptist Health, Winston-Salem, NS, USA |
| 10:00 - 10:10 | Case Presentations: The role of a multidisciplinary approach in the diagnosis and management of malignancies affecting the heart | Dr. Rachel Harris & Dr. Katie Zhang |
| 10:10 - 10:25 | Panel Discussion and Questions | |
| 10:25 - 10:45 | Break with Snacks | |
Chairs: Dr. Alexander Lyon & Dr. Frederick Locke |
||
| 10:45 - 11:05 | The Rapidly Evolving Field of Immunotherapy to Treat Malignancy: From Checkpoint Inhibitors to CAR-T | Dr. Nikhil Khushalani Vice-Chair and Associate Member, Department of Cutaneous Oncology, Moffitt Cancer Center; Associate Professor, Morsani College of Medicine, University of South Florida, Tampa, FL, USA |
| 11:05 - 11:25 | Immunotherapy Associated with Cardiotoxicity: Pathophysiology, Detection and Treatment Strategies | Dr. Tomas Neilan Associate Professor of Medicine, Harvard Medical School; Director, Cardio-oncology Program, Co-Director, Cardiac MR PET CT Program, Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA |
| 11:25 - 11:30 | Case Presentation: Can we identify those at risk for immunotherapy associated cardiovascular dysfunction? | Dr. Saad Mahmood |
| 11:30 - 11:45 | Panel Discussion and Questions | |
| 11:45 - 1:00 | Lunch (provided) | |
Moderator: Dr. Christine Brezden-Masley |
||
| 1:00 - 1:45 | Are We Too Focused on the QT Interval with Oncology Treatments? 10-minute presentations with 5 minutes for rebuttal and 15 minutes of questions | YES: Dr. Michael Fradley Director, Cardio-Oncology Program, Moffitt Cancer Center and Research Institute; Associate Professor of Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA NO: Dr. Daniel Lenihan Director, Cardio-Oncology Center of Excellence, Professor of Medicine, Washington University, St. Louis, MO, USA |
Chairs: Dr. Juan Carlos Plana & Dr. Jennifer Liu |
||
| 1:45 - 2:05 | The Role of CMR in the Evaluation and Management of the Cardio-Oncology Patient | Dr. Dinesh Thavendiranathan Director, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital; Associate Professor of Medicine, University of Toronto, Toronto, ON, Canada |
| 2:05 - 2:25 | Echocardiography in Cardio-Oncology: Strain, 3D Imaging and Disatology | Dr. Aarti Patel Director, Advanced Cardiovascular Imaging Fellowship, Assistant Professor of Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA |
| 2:25 - 3:00 | Techniques in Imaging Workshop | Drs. Eric Harrison, Jennifer Liu, Aarti Patel, Juan Carlo Plana & Dinesh Thavendiranathan |
Chairs: Dr. Samuel Wickline & Dr. Daniela Cardinale |
||
| 1:45 - 2:00 | Genomics and Personalized Medicine to Identify Those at Risk for Cardiotoxicity | Dr. Howard McLeod Medical Director, DeBartolo Family Personalized Medicine Institute; Chair, Department of Individualized Cancer Management; Senior Member, Division of Population Sciences, Moffitt Cancer Center and Research Institute, Tampa, FL, USA |
| 2:00 - 2:15 | Incorporating Cardio-Oncology in Clinical Trial Design | Dr. Laleh Amiri-Kordestani Associate Director and Cardio-oncology Liaison, Division of Oncology Products 1, Office of Hematology Oncology Products, Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA |
| 2:15 - 2:30 | Year in Review: Top Basic/Translational Research Studies in Cardio-Oncology | Dr. Bonnie Ky Director, Penn Cardio-Oncology Research Program and Penn Center for Quantitative Echocardiography, Assistant Professor of Medicine and Epidemiology, Division of Cardiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA |
| 2:30 - 2:45 | Year in Review: Top Clinical Research Studies in Cardio-Oncology | Dr. Ana Barac Director, Cardio-Oncology Program, Staff Cardiologist, MedStar Washington Hospital Center Heart and Vascular Institute; Associate Professor of Medicine and Oncology, Georgetown University School of Medicine, Washington, DC, USA |
| 2:45 - 3:00 | Panel Discussion and Questions | |
| 3:00 - 3:15 | Break with Snacks | |
Chairs: Dr. Joseph Carver & Dr. Joerg Herrmann |
||
| 3:15 - 3:30 | Developing a Cardio-Oncology Program in the Community | Dr. Richard Chazal Past President, American College of Cardiology; Medical Director, Heart and Vascular Institute, Lee Health, Fort Myers, FL, USA |
| 3:30 - 3:45 | Developing a Cardio-Oncology Program in an Academic Environment | Dr. Alexander Lyon President, British Cardio-Oncology Society; Senior Lecturer in Cardiology, Imperial College London; Consultant Cardiologist and Clinical Lead for Cardio-Oncology Services, Royal Brompton Hospital, London, United Kingdom |
| 3:45 - 4:00 | Developing a Formalized Cardio-Oncology Fellowship and Educational Curriculum | Dr. Javid Moslehi Director, Vanderbilt Cardio-Oncology Program, Assistant Professor of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA |
| 4:00 - 4:15 | The Role of Nursing in Cardio-Oncology | Dr. Anecita Fadol Associate Professor, Department of Nursing, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Natalee Roper Clinical Nurse and Cardio-Oncology Program Nurse Coordinator, Moffitt Cancer Center and Research Institute, Tampa, FL, USA |
| 4:15 - 4:30 | Cardio-Oncology Programs: An International Perspective | Dr. Ludhmila Hajjar Director, Cancer ICU and Division of Cardio-oncology, Cancer Institute, University of São Paulo (USP). Associate Professor, Department of Cardiopneumology, Instituto do Coração (InCor), Hospital das Clínicas, USP. Director, InCor, USP. Director, Cardiology ICU and Heart Failure Unit. Director, Surgical ICU, InCor-USP, São Paulo, Brazil. |
| 4:30 - 4:45 | Panel Discussion and Questions | |
| 4:45 - 5:00 | Closing Remarks & Adjourn | Co-Chairs: Dr. Michael Fradley & Dr. Roohi Ismail-Khan |
For your convenience, you may also print this program.